Tencent's New Medical AI Lab Targets Parkinson's – Synced – Medium
Chinese tech giant Tencent's first attempt in AI healthcare was the Miying platform, which has been a point of pride for CEO Huateng Ma since its 2017 launch. Supported by AI-powered medical imaging technologies, Miying assists doctors with the screening of esophageal cancer, pulmonary nodules, cervical cancer, etc. The platform has been well received in the AI and medical communities, with a fast-expanding market in Chinese top-tier AAA hospitals. At the recent International Congress of Parkinson's Disease and Movement Disorders in Hong Kong, Tencent unveiled its second layout in AI healthcare: Medical AI Lab. The lab team includes experts in machine learning, computational vision, video analytics, augmented reality (AR), natural language understanding (NLU), etc. Tencent Medical AI Lab is the latest in the company's continuing efforts on AI to Business marketing.
Dec-14-2018, 14:33:43 GMT
- Country:
- Asia > China
- North America > United States
- California (0.05)
- Genre:
- Research Report > Experimental Study (0.32)
- Industry:
- Health & Medicine > Therapeutic Area
- Musculoskeletal (0.54)
- Neurology > Parkinson's Disease (0.54)
- Oncology (0.56)
- Health & Medicine > Therapeutic Area
- Technology: